Published in J Clin Invest on December 01, 1992
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78
Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest (1994) 1.64
Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun (1996) 1.51
Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest (2007) 1.31
Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut (1998) 1.21
Peptides and gastrointestinal mucosal integrity. Gut (1995) 1.11
Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense. PLoS Genet (2010) 1.03
Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest (1998) 0.98
Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig Dis Sci (1999) 0.92
From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease. Semin Cell Dev Biol (2014) 0.89
Pierre Ménétrier and his disease. Trans Am Clin Climatol Assoc (2012) 0.85
Immunolocalization of transforming growth factor-alpha and epidermal growth factor receptor in the rat gastroduodenal area. Dig Dis Sci (1999) 0.82
Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy? Gut (2000) 0.81
Transforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats. Gut (1996) 0.81
Human transforming growth factor alpha (TGF-alpha) is digested to a smaller (1-43), less biologically active, form in acidic gastric juice. Gut (2002) 0.80
Roles for transforming growth factor-alpha in gastric physiology and pathophysiology. Yale J Biol Med (1994) 0.80
Histochemical analysis of hyperplastic stomach of TGF-alpha transgenic mice. Dig Dis Sci (1997) 0.79
Ligands for histamine H(3) receptors modulate cell proliferation and migration in rat oxyntic mucosa. Br J Pharmacol (2002) 0.78
Transforming growth factor-alpha (TGF-alpha) levels in human proximal gastrointestinal epithelium. Effect of mucosal injury and acid inhibition. Dig Dis Sci (1997) 0.77
Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury. BMC Gastroenterol (2006) 0.77
Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts. Proc (Bayl Univ Med Cent) (2004) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem (1969) 15.62
Inositol trisphosphate and diacylglycerol as second messengers. Biochem J (1984) 14.37
Polyamines. Annu Rev Biochem (1984) 12.92
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A (1980) 6.32
Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology (1979) 5.73
Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell (1984) 5.39
Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science (1984) 3.62
Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science (1986) 3.52
Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature (1990) 3.20
Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. Proc Natl Acad Sci U S A (1989) 3.17
Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells. Science (1988) 2.62
Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem (1983) 2.42
Regulation of cellular glutathione. Am J Physiol (1989) 2.26
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (1980) 2.24
Salicylate damage to the gastric mucosal barrier. N Engl J Med (1967) 1.92
Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (1982) 1.80
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
Free radicals and lipid peroxidation in ethanol- or aspirin-induced gastric mucosal injury. Dig Dis Sci (1987) 1.76
Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul (1991) 1.73
Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest (1989) 1.69
Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. Proc Natl Acad Sci U S A (1986) 1.69
Sulfhydryl compounds may mediate gastric cytoprotection. Science (1981) 1.65
Tyrosine phosphorylation of phospholipase C-II in vitro by the epidermal growth factor receptor. J Biol Chem (1989) 1.60
Cellular localisation of human urogastrone/epidermal growth factor. Nature (1978) 1.60
Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med (1988) 1.58
Decarboxylation of ornithine and lysine in rat tissues. Biochim Biophys Acta (1979) 1.53
Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gastroenterology (1981) 1.52
Transforming growth factor-alpha: structure and biological activities. J Cell Biochem (1986) 1.50
Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. Proc Natl Acad Sci U S A (1983) 1.48
Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands. Gut (1978) 1.41
Epidermal growth factor receptor of the intestinal enterocyte. Localization to laterobasal but not brush border membrane. J Biol Chem (1989) 1.41
Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology (1984) 1.38
Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract. Int J Cancer (1989) 1.22
Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J Histochem Cytochem (1985) 1.22
Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut (1981) 1.21
Interaction between oxygen radicals and gastric mucin. Am J Physiol (1987) 1.21
Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology (1992) 1.20
Effect of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn J Pharmacol (1983) 1.17
Ethanol damage to canine oxyntic glandular mucosa. Proc Soc Exp Biol Med (1967) 1.16
Transforming growth factor alpha inhibits secretion of gastric acid. Proc Natl Acad Sci U S A (1986) 1.14
Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha. J Pharmacol Exp Ther (1987) 1.13
Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa. Br J Cancer (1989) 1.13
Mitogenic response of canine fundic epithelial cells in short-term culture to transforming growth factor alpha and insulinlike growth factor I. J Clin Invest (1991) 1.12
Specific receptors for epidermal growth factor in rat intestinal microvillus membranes. Am J Physiol (1988) 1.09
Effects of epidermal growth factor on acid secretion from guinea pig gastric mucosa: in vitro analysis. Gastroenterology (1985) 1.07
Effects of epidermal growth factor on gastrointestinal secretions. Am J Physiol (1984) 1.05
Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology (1990) 1.02
The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action. Regul Pept (1988) 1.02
Protective role of intracellular glutathione against ethanol-induced damage in cultured rat gastric mucosal cells. Gastroenterology (1990) 0.98
Comparison of antacid, sucralfate, cimetidine, and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med (1985) 0.97
Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissues. Life Sci (1979) 0.97
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis (1989) 0.96
The role of acid in the pathogenesis of aspirin-induced gastrointestinal erosions and hemorrhage. Am J Dig Dis (1973) 0.95
Role of glutathione in gastric mucosal cytoprotection. Am J Physiol (1984) 0.95
Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. Gut (1988) 0.93
Gastric glutathione depletion and acute ulcerogenesis by diethylmaleate given subcutaneously to rats. Life Sci (1981) 0.92
Relations between gastric glutathione and the ulcerogenic action of non-steroidal anti-inflammatory drugs. Arch Int Pharmacodyn Ther (1983) 0.88
Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism. Surgery (1990) 0.88
Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection. J Pharmacol Exp Ther (1989) 0.87
Electron microscopic evidence for epidermal growth factor receptor (EGF-R)-like immunoreactivity associated with the basolateral surface of gastric parietal cells. Acta Pathol Jpn (1987) 0.86
Protection by metals against ethanol-induced gastric mucosal injury in the rat. Comparative biochemical and pharmacologic studies implicate protein sulfhydryls. Gastroenterology (1986) 0.86
Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats. Am J Med (1989) 0.84
Characterization of mucous cell synthetic functions in a new primary canine gastric mucous cell culture system. Am J Physiol (1990) 0.83
The myth of the mucus barrier. Gastroenterol Clin Biol (1985) 0.83
Potentiation of aspirin-induced gastric lesions by exposure to cold in rats. Role of acid secretion, mucosal blood flow, and gastric mucosal prostanoid content. Gastroenterology (1989) 0.82
The effect of sialoadenectomy on gastric mucosal integrity in the rat: roles of epidermal growth factor and prostaglandin E2. Can J Physiol Pharmacol (1989) 0.80
On the cytoprotective action of sulfhydryl-containing substances. Acta Physiol Acad Sci Hung (1982) 0.79
Prostaglandin protects isolated guinea pig chief cells against ethanol injury via an increase in diacylglycerol. J Clin Invest (1990) 0.79
Role of sulphydryl compounds in the defense of rat gastric epithelial cells against oxygen reactive metabolite-induced damage. Ital J Gastroenterol (1991) 0.78
Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study. Am J Med (1987) 0.78
Protective effect of human epidermal growth factor against the experimental gastric mucosal lesions in rats. Life Sci (1990) 0.77
Characterization of the epidermal growth factor receptor in the gastric mucosa. Digestion (1990) 0.76
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell (2001) 5.84
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem (2000) 5.00
Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature (1987) 4.19
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet (2009) 3.99
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology (1993) 3.76
Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res (1994) 3.63
Trefoil peptides: less clandestine in the intestine. Science (1996) 3.60
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med (1989) 3.39
A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys (1994) 3.29
Conversion of diploidy to haploidy. Nature (2000) 3.28
Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Cancer Res (2001) 3.18
Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology (1999) 3.06
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99
Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology (2000) 2.99
DNA repair and colorectal cancer. Gastroenterol Clin North Am (1996) 2.88
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell (1990) 2.63
Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst (1995) 2.62
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A (1992) 2.51
Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg (1991) 2.41
Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res (1996) 2.37
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat Med (1997) 2.32
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology (2000) 2.27
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer (2003) 2.26
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res (2000) 2.24
Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol (2000) 2.20
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest (2000) 2.17
Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res (1995) 2.17
Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A (1982) 2.17
A new type of transforming growth factor-beta, TGF-beta 3. EMBO J (1988) 2.12
Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci U S A (1989) 2.09
JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A (1999) 2.08
Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A (1995) 2.07
Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A (1988) 2.03
Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res (1997) 1.96
Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 1.96
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog (1991) 1.95
Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology (1998) 1.90
Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology (1999) 1.88
Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA. J Natl Cancer Inst (1997) 1.88
Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88
Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene (2005) 1.81
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens. J Clin Oncol (1989) 1.78
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol (1989) 1.76
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology (1995) 1.74
Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res (1996) 1.74
Production of transforming growth factors by human colon cancer lines. Cancer Res (1986) 1.74
Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst (1984) 1.74
Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science (1996) 1.73
Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res (2001) 1.70
Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer (2001) 1.70
Cell biology of wound healing. Int Rev Cytol (1996) 1.69
Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest (1989) 1.69
JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology (2000) 1.68
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol (1987) 1.68
Transforming growth factors and control of neoplastic cell growth. J Cell Biochem (1987) 1.67
Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst (1999) 1.67
Steady-state regulation of the human DNA mismatch repair system. J Biol Chem (2000) 1.66
Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med (1987) 1.66
Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology (1996) 1.65
Stereotactic gamma knife radiosurgery. Initial North American experience in 207 patients. Arch Neurol (1990) 1.64
Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst (1990) 1.61
Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res (1987) 1.61
Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene (2001) 1.59
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res (2001) 1.58
A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. J Natl Cancer Inst (1991) 1.57
Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol (1986) 1.56
H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3. Oncogene (2010) 1.56
Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys (1996) 1.56
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta. Breast Cancer Res (2000) 1.54
Reversible drug-induced oxyntic atrophy in rats. Gastroenterology (2000) 1.53
Fatal progression of posttraumatic dural arteriovenous fistulas refractory to multimodal therapy. Case report. J Neurosurg (2001) 1.53
Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol (1998) 1.52
Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am J Pathol (1993) 1.52
Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell (2001) 1.52
Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine. J Clin Invest (1996) 1.49
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene (2011) 1.49
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol (2000) 1.48
Regulation of canine gastric mucin synthesis and phospholipid secretion by acid secretagogues. Gastroenterology (1992) 1.46
Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc Natl Acad Sci U S A (1996) 1.46
ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Cancer Res (2001) 1.44
Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells. Exp Cell Res (2000) 1.42
Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst (1997) 1.40
Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem (1994) 1.40
Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles. Genes Dev (1993) 1.40
Nashville experience with liver transplantation in Veterans Administration patients. J Surg Res (1997) 1.39
Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer (1987) 1.37
Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol Cell Biol (1996) 1.36
Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol (2001) 1.36
A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology (1997) 1.35
Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol (1985) 1.34